HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- Population Health Research Institute
- Study ID
- NCT04743765
- Status
- Recruiting
Conditions
- Hip Fractures
- Myocardial Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Accelerated medical clearance and surgery — OTHERRapid medical clearance with targeted arrival to the operating room within 6 hours of eligibility criteria criteria met.
Study Details
The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.
Key Dates
- Start date
- Nov 22, 2021
- Status verified
- Sep 2025
- Primary completion
- Feb 28, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 1,100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Accelerated medical clearance and surgeryAccelerated medical clearance and targeted arrival to the operating room within 6 hours of eligibility criteria met.
- No Intervention: Standard surgical careHip fracture repair and surgical care according to treating institution guidelines.
Primary Outcome Measure
All cause mortality [ Time Frame: Within 90 days post randomization ]
Central Contacts
- Valerie Harvey905-297-3479
Locations (19)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Chandler Regional Medical Center | Chandler | Arizona | 85224 | Jessica Hummell William Naylor, MD (PRINCIPAL_INVESTIGATOR) |
| The Regents of the University of California | Davis | California | 95618 | Julia Martin Gaby Zumaran Augustine Saiz, MD (PRINCIPAL_INVESTIGATOR) |
| Yale New Haven Hospital | New Haven | Connecticut | 06520 | Matthew Riedel, MD (PRINCIPAL_INVESTIGATOR) |
| Emory University at Grady Memorial Hospital | Atlanta | Georgia | 30322 | Morgan Fuller Roberto Hernandez Irizarry, MD (PRINCIPAL_INVESTIGATOR) |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | Taj-Jamal Andrew, MD Ronald Delanois, MD (PRINCIPAL_INVESTIGATOR) |
| University of Maryland | Baltimore | Maryland | 20742 | Heather Phipps Gerard Slobogean, MD (PRINCIPAL_INVESTIGATOR) |
| Tufts Medical Center | Boston | Massachusetts | 02111 | Monica Hennessey Scott Ryan, MD (PRINCIPAL_INVESTIGATOR) |
| Lahey Hospital and Medical Center | Burlington | Massachusetts | 01805 | John Garfi Andrew Marcantonio, MD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan | Ann Arbor | Michigan | 48109 | Lyle Johnson Jaimo Ahn, MD (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic | Rochester | Minnesota | 55905 | Brandon Yuan, MD (PRINCIPAL_INVESTIGATOR) |
| Bryan Medical Center | Lincoln | Nebraska | 68506 | Kristin Williams Bobbi Clinch Steven Shannon, MD (PRINCIPAL_INVESTIGATOR) |
| University Medical Center of Southern Nevada | Las Vegas | Nevada | 89102 | Robert Panganiban Robert Bimbi Erik Kubiak, MD (PRINCIPAL_INVESTIGATOR) |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | Jon Mikael Anderson Ida Leah Gitajn, MD (PRINCIPAL_INVESTIGATOR) |
| Montefiore Medical Center | The Bronx | New York | 10467 | Lauren Crocco, MD (PRINCIPAL_INVESTIGATOR) |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Laura Stiegel Nicolas Piuzzi, MD (PRINCIPAL_INVESTIGATOR) |
| Oregon Health and Science University | Portland | Oregon | 97239 | Talia Trapalis Zachary Working, MD (PRINCIPAL_INVESTIGATOR) |
| St. Luke's University Health Network | Bethlehem | Pennsylvania | 18015 | Douglas Lundy, MD (PRINCIPAL_INVESTIGATOR) |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | Sterling Boutte Stephen Warner, MD (PRINCIPAL_INVESTIGATOR) |
| University of Wisconsin | Madison | Wisconsin | 53715 | Kristoffer Sladky Christopher Domes, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chandler, AZ
Related Studies
- Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood TransfusionPHASE4 · Recruiting · Gregory M Georgiadis MD · Toledo, Ohio
- MDR - PMCF Study for Taperloc Complete StemsRecruiting · Zimmer Biomet · Henderson, Nevada
- NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury TrialPHASE2 · Recruiting · Kaiser Permanente · San Francisco, California
- Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip FracturePHASE4 · Recruiting · University of Minnesota · Minneapolis, Minnesota